Literature DB >> 6138595

Prednisone and methylprednisolone disposition in the lung.

A C Braude, A S Rebuck.   

Abstract

To compare the penetrability of methylprednisolone into lung tissue with that of prednisone, blood and bronchoalveolar lavage (BAL) fluid levels of methylprednisolone and prednisone were measured in 17 patients with a variety of lung diseases. To correct for variations in the quantity of lung fluid obtained by BAL, steroid levels were expressed in relation to creatinine concentrations. The level of methylprednisolone penetration in the pulmonary parenchyma, expressed by the slope of the relation between blood and BAL fluid, was 0.5 (r = 0.8; p less than 0.03). By contrast, despite serum levels of between 59 and 219 ng/ml, prednisone could not be detected in the BAL fluid in 3 patients; the overall correlation between blood and BAL fluid for all patients was r = 0.5 (slope = 0.3; p less than 0.1). Thus methylprednisolone is better able than prednisone to penetrate lung acini.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6138595     DOI: 10.1016/s0140-6736(83)90981-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

1.  Bronchoalveolar mast cells in sarcoidosis: increased numbers and accentuation of mediator release.

Authors:  K C Flint; K B Leung; B N Hudspith; J Brostoff; F L Pearce; D Geraint-James; N M Johnson
Journal:  Thorax       Date:  1986-02       Impact factor: 9.139

2.  Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study.

Authors:  C R Jenkins; A J Woolcock
Journal:  Thorax       Date:  1988-05       Impact factor: 9.139

Review 3.  Assessment of drug disposition in the lung.

Authors:  A S Rebuck; A C Braude
Journal:  Drugs       Date:  1984-12       Impact factor: 9.546

4.  Glucocorticoid insensitive asthma: a one year clinical follow up pilot study.

Authors:  P Demoly; D Jaffuel; M Mathieu; H Sahla; P Godard; F B Michel; J Bousquet
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

5.  Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults.

Authors:  S J Szefler; W F Ebling; J W Georgitis; W J Jusko
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial.

Authors:  Keivan Ranjbar; Mohsen Moghadami; Alireza Mirahmadizadeh; Mohammad Javad Fallahi; Vahid Khaloo; Reza Shahriarirad; Amirhossein Erfani; Zohre Khodamoradi; Mohammad Hasan Gholampoor Saadi
Journal:  BMC Infect Dis       Date:  2021-04-10       Impact factor: 3.090

7.  Methylprednisolone Treatment Versus Standard Supportive Care for Adult COVID-19 Mechanically Ventilated, Acute Respiratory Distress Syndrome Patients.

Authors:  Masood Ur Rahman; Satish Chandrasekhar Nair; Mehraj Ud Din; Mohammed Reidwan Dar; Murriam Masood; Al Reem Salem Al Menhali; Mouza Mohammed Al Nuaimi; Jayadevan Sreedharan; Huda Imam Gasmelseed; Asad Afroz Khan
Journal:  SN Compr Clin Med       Date:  2022-01-03

8.  Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients.

Authors:  Mohammed Abdel Monem Saeed; Alaa Hussein Mohamed; Ahmed Hassan Owaynat
Journal:  Egypt J Intern Med       Date:  2022-02-15

Review 9.  General Adaptation in Critical Illness: Glucocorticoid Receptor-alpha Master Regulator of Homeostatic Corrections.

Authors:  Gianfranco Umberto Meduri; George P Chrousos
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-22       Impact factor: 5.555

10.  Comparison between Dexamethasone and Methylprednisolone Therapy in Patients with COVID-19 Pneumonia Admitted to Non-Intensive Medical Units.

Authors:  Roberta Buso; Francesco Cinetto; Alessandro Dell'Edera; Nicola Veneran; Cesarina Facchini; Valeria Biscaro; Stefania Schiavon; Elisa Vian; Ugo Grossi; Giacomo Zanus; Mario Giobbia; Riccardo Scarpa; Carlo Agostini; Marcello Rattazzi; Carla Felice
Journal:  J Clin Med       Date:  2021-12-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.